These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2701646)

  • 21. A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production.
    Neighbors M; Xu X; Barrat FJ; Ruuls SR; Churakova T; Debets R; Bazan JF; Kastelein RA; Abrams JS; O'Garra A
    J Exp Med; 2001 Aug; 194(3):343-54. PubMed ID: 11489953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of treatment with interleukin-1 and tumor necrosis factor on Pseudomonas aeruginosa lung infection in a granulocytopenic mouse model.
    Amura CR; Fontan PA; Sanjuan N; Sordelli DO
    Clin Immunol Immunopathol; 1994 Nov; 73(2):261-6. PubMed ID: 7923933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
    Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
    Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes.
    Kelly JP; Bancroft GJ
    Eur J Immunol; 1996 Feb; 26(2):356-64. PubMed ID: 8617304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice.
    van Enckevort FH; Netea MG; Hermus AR; Sweep CG; Meis JF; Van der Meer JW; Kullberg BJ
    Med Mycol; 1999 Dec; 37(6):419-26. PubMed ID: 10647123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human recombinant interleukin-1 alpha protection against the lethality of endotoxin and experimental sepsis in mice.
    Alexander HR; Doherty GM; Fraker DL; Block MI; Swedenborg JE; Norton JA
    J Surg Res; 1991 May; 50(5):421-4. PubMed ID: 2038179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
    Belizario JE; Dinarello CA
    Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia.
    Smith SR; Terminelli C; Kenworthy-Bott L; Calzetta A; Donkin J
    J Leukoc Biol; 1994 Jun; 55(6):711-8. PubMed ID: 8195696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low dosages of interleukin 1 protect mice against lethal cerebral malaria.
    Curfs JH; van der Meer JW; Sauerwein RW; Eling WM
    J Exp Med; 1990 Nov; 172(5):1287-91. PubMed ID: 2230643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection by dexamethasone from a lethal infection with Listeria monocytogenes in mice.
    Nakane A; Okamoto M; Asano M; Kohanawa M; Satoh Y; Minagawa T
    FEMS Immunol Med Microbiol; 1994 Aug; 9(2):163-70. PubMed ID: 7804167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia.
    Marion CR; Wang J; Sharma L; Losier A; Lui W; Andrews N; Elias JA; Kazmierczak BI; Roy CR; Dela Cruz CS
    Infect Immun; 2016 Jul; 84(7):2094-2104. PubMed ID: 27141083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of interleukin 1 alpha on survival in a murine model of burn wound sepsis.
    Silver GM; Gamelli RL; O'Reilly M; Hebert JC
    Arch Surg; 1990 Jul; 125(7):922-5. PubMed ID: 2369319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.
    Cross AS; Sadoff JC; Kelly N; Bernton E; Gemski P
    J Exp Med; 1989 Jun; 169(6):2021-7. PubMed ID: 2659724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation of host resistance to microbial infections by recombinant human interleukin-1 alpha.
    Minami A; Fujimoto K; Ozaki Y; Nakamura S
    Infect Immun; 1988 Dec; 56(12):3116-20. PubMed ID: 3263325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a.
    Ozaki Y; Ohashi T; Minami A; Nakamura S
    Infect Immun; 1987 Jun; 55(6):1436-40. PubMed ID: 3553002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1 alpha prevention of the lethality of Escherichia coli peritonitis.
    Lange JR; Alexander HR; Merino MJ; Doherty GM; Norton JA
    J Surg Res; 1992 Jun; 52(6):555-9. PubMed ID: 1528030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor-independent IL-6 production during murine listeriosis.
    Havell EA; Sehgal PB
    J Immunol; 1991 Jan; 146(2):756-61. PubMed ID: 1987284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    Neta R; Oppenheim JJ; Douches SD
    J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth of Listeria monocytogenes in murine macrophages and its modulation by cytokines; activation of bactericidal activity by interleukin-4 and interleukin-6.
    Denis M
    Can J Microbiol; 1991 Apr; 37(4):253-7. PubMed ID: 1913336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.